GlobeImmune Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Sales/Revenue
5,107.80
14,641.60
22,518.40
5,966.40
6,457.70
Cost of Goods Sold (COGS) incl. D&A
13,015.50
925.50
771.30
295.20
-
Gross Income
7,907.60
13,716.10
21,747.10
5,671.20
-
SG&A Expense
4,685.80
17,682.60
14,059.40
11,490.30
9,237.30
EBIT
12,593.50
3,966.50
7,687.70
5,819.10
2,966.90
Unusual Expense
1,135.00
1,951.50
1,842.60
6,591.10
-
Non Operating Income/Expense
2.60
0.30
62.20
40.00
200.00
Interest Expense
-
-
-
3,890.70
-
Pretax Income
13,724.80
2,014.70
9,592.50
16,260.90
2,766.90
Income Tax
-
-
115.80
-
-
Consolidated Net Income
13,724.80
2,014.70
9,476.70
16,260.90
2,766.90
Net Income
13,724.80
2,014.70
9,476.70
16,260.90
2,766.90
Net Income After Extraordinaries
13,724.80
2,014.70
9,476.70
16,260.90
2,766.90
Net Income Available to Common
25,041.30
14,119.00
3,408.40
23,434.80
2,766.90
EPS (Basic)
4.35
2.45
0.59
8.04
0.48
Basic Shares Outstanding
5,751.60
5,751.60
5,751.60
2,914.70
5,751.60
EPS (Diluted)
4.35
2.45
0.59
8.04
0.48
Diluted Shares Outstanding
5,751.60
5,751.60
5,751.60
2,914.70
5,751.60
EBITDA
11,641.40
3,041.00
8,459.00
5,524.00
2,779.60
Non-Operating Interest Income
1.10
-
-
-
-
Preferred Dividends
11,316.50
12,104.30
12,885.10
7,173.90
-
About GlobeImmune
View Profile
